» Articles » PMID: 24040515

Prognostic Significance of MiR-194 in Endometrial Cancer

Overview
Journal Biomark Res
Publisher Biomed Central
Date 2013 Sep 17
PMID 24040515
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Endometrial cancer (EC) is the leading malignant tumor occurring in the female genital tract and some subtypes are highly invasive and metastatic. miRNAs are small non-coding RNAs that have a broad impact on cancer progression. In particular, miR-194 regulates epithelial to mesenchymal transition (EMT) by suppressing the expression of BMI-1 in EC. In this retrospective study, the clinical significance of miR-194 was investigated in archival EC specimens. We extracted total RNA from thirty-two EC samples and quantified the expression level of miR-194. We discovered that the expression level of miR-194 was significantly (P = 0.03) lower in type I EC patients with more advanced stage. In addition, patients with higher miR-194 levels have better prognosis than those with lower miR-194 levels (P = 0.0067; Cut-off value of miR-194 = 0.3). These results indicate that miR-194 has potential to serve as prognostic biomarker for EC patients.

Citing Articles

Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma.

Yuen J, Hwang G, Fesler A, Intriago E, Pal A, Ojha A Mol Ther Oncol. 2024; 32(1):200769.

PMID: 38596306 PMC: 10869788. DOI: 10.1016/j.omton.2024.200769.


The Role of MicroRNAs in Development of Endometrial Cancer: A Literature Review.

Indumati S, Apurva B, Gaurav G, Nehakumari S, Nishant V J Reprod Infertil. 2023; 24(3):147-165.

PMID: 37663424 PMC: 10471942. DOI: 10.18502/jri.v24i3.13271.


The Immune-related ceRNA Network in Prognosis of Cervical Cancer.

Dhandapani H, Bose M, Kesavan S Asian Pac J Cancer Prev. 2022; 23(10):3347-3354.

PMID: 36308358 PMC: 9924325. DOI: 10.31557/APJCP.2022.23.10.3347.


The Role of miRNAs in the Regulation of Endometrial Cancer Invasiveness and Metastasis-A Systematic Review.

Klicka K, Grzywa T, Klinke A, Mielniczuk A, Wlodarski P Cancers (Basel). 2021; 13(14).

PMID: 34298609 PMC: 8304659. DOI: 10.3390/cancers13143393.


MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review.

Favier A, Rocher G, Larsen A, Delangle R, Uzan C, Sabbah M Cancers (Basel). 2021; 13(5).

PMID: 33800944 PMC: 7961497. DOI: 10.3390/cancers13051137.


References
1.
Bokhman J . Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983; 15(1):10-7. DOI: 10.1016/0090-8258(83)90111-7. View

2.
Colas E, Pedrola N, Devis L, Ertekin T, Campoy I, Martinez E . The EMT signaling pathways in endometrial carcinoma. Clin Transl Oncol. 2012; 14(10):715-20. DOI: 10.1007/s12094-012-0866-3. View

3.
He L, Thomson J, Hemann M, Hernando-Monge E, Mu D, Goodson S . A microRNA polycistron as a potential human oncogene. Nature. 2005; 435(7043):828-33. PMC: 4599349. DOI: 10.1038/nature03552. View

4.
Glinsky G, Berezovska O, Glinskii A . Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest. 2005; 115(6):1503-21. PMC: 1136989. DOI: 10.1172/JCI23412. View

5.
Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F . A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103(7):2257-61. PMC: 1413718. DOI: 10.1073/pnas.0510565103. View